Question 1

Which nursing diagnosis is appropriate for a patient who has started aminoglycoside therapy?&#10;A) Constipation&#10;B) Risk for injury (renal damage)&#10;C) Disturbed body image related to gynecomastia&#10;D) Imbalanced nutrition, less than body requirements, related to nausea

Accepted Answer

Patients on aminoglycoside therapy have an increased risk for injury caused by nephrotoxicity. The other options are incorrect.

Question 2

The nurse is administering intravenous vancomycin (Vancocin) to a patient who has had gastrointestinal surgery. Which nursing measures are appropriate? (Select all that apply.)&#10;A) Monitoring serum creatinine levels&#10;B) Restricting fluids while the patient is on this medication&#10;C) Warning the patient that a flushed feeling or facial itching may occur&#10;D) Instructing the patient to report dizziness or a feeling of fullness in the ears&#10;E) Reporting a trough drug level of 11 mcg/mL and holding the drug&#10;F) Reporting a trough drug level of 24 mcg/mL and holding the drug

Accepted Answer

Constant monitoring for drug-related neurotoxicity, nephrotoxicity, ototoxicity, and superinfection remain critical to patient safety. Monitor for nephrotoxicity by monitoring serum creatinine levels. Ototoxicity may be indicated if the patient experiences dizziness or a feeling of fullness in the ears, and these symptoms must be reported immediately. Vancomycin infusions may cause red man syndrome, which is characterized by flushing of the neck and face and a decrease in blood pressure. In addition, adequate hydration (at least 2 liters of fluids every 24 hours unless contraindicated) is most important to prevent nephrotoxicity. Optimal trough blood levels of vancomycin are 10 to 20 mcg/mL; therefore, the drug should not be administered when there is a trough level of 24 mcg/mL.

Question 3

The nurse is administering a vancomycin (Vancocin) infusion. Which measure is appropriate for the nurse to implement in order to reduce complications that may occur with this drug's administration?&#10;A) Monitoring blood pressure for hypertension during the infusion&#10;B) Discontinuing the drug immediately if red man syndrome occurs&#10;C) Restricting fluids during vancomycin therapy&#10;D) Infusing the drug over at least 1 hour

Accepted Answer

Infuse the medication over at least 1 hour to reduce the occurrence of red man syndrome. Adequate hydration (at least 2 liters of fluid in 24 hours) during vancomycin therapy is important for the prevention of nephrotoxicity. Hypotension may occur during the infusion, especially if it is given too rapidly.

Question 4

A patient is receiving aminoglycoside therapy and will be receiving a beta-lactam antibiotic as well. The patient asks why two antibiotics have been ordered. What is the nurse's best response?&#10;A) &#34;The combined effect of both antibiotics is greater than each of them alone.&#34;&#10;B) &#34;One antibiotic is not strong enough to fight the infection.&#34;&#10;C) &#34;We have not yet isolated the bacteria, so the two antibiotics are given to cover a wide range of microorganisms.&#34;&#10;D) &#34;We can give a reduced amount of each one if we give them together.&#34;

Accepted Answer

Aminoglycosides are often used in combination with other antibiotics, such as beta-lactams or vancomycin, in the treatment of various infections because the combined effect of the two antibiotics is greater than that of either drug alone.

Question 5

A 79-year-old patient is receiving a quinolone as treatment for a complicated incision infection. The nurse will monitor for which adverse effect that is associated with these drugs?&#10;A) Neuralgia&#10;B) Double vision&#10;C) Hypotension&#10;D) Tendonitis and tendon rupture

Accepted Answer

A black-box warning is required by the U.S. Food and Drug Administration for all quinolones because of the increased risk for tendonitis and tendon rupture with use of the drugs. This effect is more common in elderly patients, patients with renal failure, and those receiving concurrent glucocorticoid therapy (e.g., prednisone). The other options are not common adverse effects.

Question 6

A patient with a Pseudomonas species urinary infection will be receiving amikacin (Amikin) 15 mg/kg once daily via intravenous infusion. The patient weighs 198 pounds, and the medication is available in an injection solution strength of 250 mg/mL. How many milliliters of medication will be drawn up for this injection? (Record answer using one decimal place.)

Accepted Answer

The answer of A patient with a Pseudomonas species urinary...

Question 7

A patient who has been hospitalized for 2 weeks has developed a pressure ulcer that contains multidrug-resistant Staphylococcus aureus ( MRSA ). Which drug would the nurse expect to be chosen for therapy?

A) metronidazole ( Flagyl )
B) ciprofloxacin ( Cipro )
C) vancomycin ( Vancocin )
D) tobramycin ( Nebcin )

Accepted Answer

Vancomycin is the drug of choice for the treatment of MRSA. The other drugs are not used for MRSA.

Question 8

A patient has been diagnosed with Klebsiella pneumoniae carbapenemases ( KPC ). The nurse expects to see orders for which drug?&#10;A) dapsone ( Cubicin ), a miscellaneous antibiotic&#10;B) ciprofloxacin ( Cipro ), a quinolone&#10;C) linezolid ( Zyvox ), an oxazolidinone&#10;D) colistimethate sodium ( Coly-Mycin ), a polypeptide antibiotic

Accepted Answer

Colistimethate (Coly-Mycin), commonly referred to as colistin, is now being used again, often as one of the only drugs available to treat KPC. The other options are incorrect.

Question 9

A patient will be receiving nitrofurantoin (Macrodantin) treatment for a urinary tract infection. The nurse is reviewing the patient's history and will question the nitrofurantoin order if which disorder is present in the history? (Select all that apply.)

A) Liver disease
B) Coronary artery disease
C) Hyperthyroidism
D) Type 1 diabetes mellitus
E) Chronic renal disease

Accepted Answer

Nitrofurantoin is contraindicated in cases of known drug allergy and also in cases of significant renal function impairment, because the drug concentrates in the urine. Because adverse effects include hepatotoxicity, which is rare but often fatal, the nurse should also question the order if liver disease is present. The other options are not contraindications.

Question 10

The nurse who is administering aminoglycoside therapy must monitor the patient closely for signs of toxicity as manifested by which of these conditions? (Select all that apply.)&#10;A) Electrocardiogram changes&#10;B) Hearing loss&#10;C) Dizziness&#10;D) Constipation&#10;E) Decreasing hemoglobin level&#10;F) Rising serum creatinine level

Accepted Answer

Patients on aminoglycoside therapy must be monitored for signs of nephrotoxicity (rising serum creatinine level) and ototoxicity (hearing loss, dizziness). The other options are not signs of toxicity.

Question 11

The nurse checks the patient's laboratory work prior to administering a dose of vancomycin (Vancocin) and finds that the trough vancomycin level is 24 mcg/mL. What will the nurse do next?&#10;A) Administer the vancomycin as ordered.&#10;B) Hold the drug, and administer 4 hours later.&#10;C) Hold the drug, and notify the prescriber.&#10;D) Repeat the test to verify results.

Accepted Answer

The answer of The nurse checks the patient's laboratory work...

Question 12

When a patient is on aminoglycoside therapy, the nurse will monitor the patient for which indicators of potential toxicity? A) Fever B) White blood cell count of 8000 cells/mm³ C) Tinnitus and dizziness D) Decreased blood urea nitrogen (BUN) levels

Accepted Answer

The answer of When a patient is on aminoglycoside therapy,...

Question 13

The nurse is reviewing the medication orders for a patient who will be receiving linezolid (Zyvox) therapy. Which other medication or medication class, if ordered, would be a potential interaction concern?

A) Calcium channel blockers
B) Phenytoin
C) Anticoagulants
D) Selective serotonin reuptake inhibitor antidepressants

Accepted Answer

The answer of The nurse is reviewing the medication orders...

Deck 39: Antibiotics Part 2